HARVARD BIOSCIENCE, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
HARVARD BIOSCIENCE, INC. (HBIO) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $904.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-08-11
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $904.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.81M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $894.00K.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $1.79M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $904.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $1.81M 10-Q · filed 2026-05-12 |
| 2025-09-30 | $894.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.79M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $2.99M 10-Q · filed 2025-05-12 |
| 2024-09-30 | $1.31M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.67M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.05M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $1.38M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.78M 10-Q · filed 2023-08-08 |
| 2022-09-30 | $1.56M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.87M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.37M 10-Q · filed 2022-05-04 |
| 2021-09-30 | $1.46M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $2.92M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $4.37M 10-Q · filed 2021-05-07 |
| 2020-09-30 | $1.68M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $2.84M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $4.10M 10-Q · filed 2020-05-08 |
| 2019-09-30 | $5.60M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $5.60M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |